NovoCure Ltd Quarterly Income Tax Expense (Benefit) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
NovoCure Ltd quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2014 to Q3 2024.
  • NovoCure Ltd Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $8.99M, a 611% increase year-over-year.
  • NovoCure Ltd Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $35.3M, a 207% increase year-over-year.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2023 was $15.3M, a 43.2% increase from 2022.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2022 was $10.7M, a 70.3% increase from 2021.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2021 was $6.28M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $35.3M $8.99M +$7.72M +611% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $27.6M $10.6M +$7.13M +203% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $20.4M $7.12M +$5.14M +259% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $15.3M $8.55M +$3.8M +80.1% Oct 1, 2023 Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $11.5M $1.26M -$1.9M -60% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $13.4M $3.51M +$2.86M +439% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $10.5M $1.98M -$151K -7.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $10.7M $4.75M +$3.86M +436% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $6.83M $3.16M +$568K +21.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $6.26M $652K -$754K -53.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $7.01M $2.13M +$738K +52.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $6.28M $885K -$3.02M -77.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $9.3M $2.59M +$836K +47.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $8.46M $1.41M -$990K -41.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $9.45M $1.39M +$11.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 -$1.71M $3.91M +$9.76M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$11.5M $1.76M +$2.39M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$13.9M $2.4M +$1.17M +95.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$15M -$9.77M -$13.4M -367% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 -$1.59M -$5.85M -$10.7M -222% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $9.07M -$630K -$4.68M -116% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $13.7M $1.23M -$4.34M -78% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-10-02
Q1 2019 $18.1M $3.66M +$467K +14.6% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-10-02
Q4 2018 $17.6M $4.81M +$752K +18.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $16.9M $4.05M +$628K +18.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $16.2M $5.57M +$2.1M +60.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $14.1M $3.19M +$968K +43.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $13.2M $4.06M +$2.62M +182% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $10.5M $3.42M +$249K +7.85% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-25
Q2 2017 $10.3M $3.46M +$641K +22.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $9.66M $2.23M -$724K -24.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $10.4M $1.44M -$10K -0.69% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $10.4M $3.17M +$2.2M +225% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $8.19M $2.82M +$1.55M +121% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $6.65M $2.95M +$2.21M +301% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $4.43M $1.45M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $976K +$614K +170% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $1.28M Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $736K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 $362K Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.